– Eight abstracts, including two oral presentations, feature new clinical data from Astellas’ oncology portfolio and two lead pipeline programs across a broad range of cancer types – TOKYO, Sept. 11, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.